{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-25",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "49884-604",
      "marketing_end_date": "20260930",
      "generic_name": "lamotrigine extended release",
      "labeler_name": "Par Health USA, LLC",
      "brand_name": "Lamotrigine Extended Release",
      "active_ingredients": [
        {
          "name": "LAMOTRIGINE",
          "strength": "250 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "49884-604-11",
          "description": "30 TABLET in 1 BOTTLE (49884-604-11)",
          "marketing_start_date": "20130118",
          "marketing_end_date": "20260930",
          "sample": false
        }
      ],
      "openfda": {
        "manufacturer_name": [
          "Par Health USA, LLC"
        ],
        "rxcui": [
          "850087",
          "850091",
          "900156",
          "900164",
          "1098608",
          "1146690"
        ],
        "spl_set_id": [
          "fb59c76a-9b6f-40ea-ac3a-58c3195c4377"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000175753",
          "N0000008486",
          "N0000175751",
          "N0000187061",
          "N0000000191"
        ],
        "pharm_class_epc": [
          "Anti-epileptic Agent [EPC]",
          "Mood Stabilizer [EPC]"
        ],
        "pharm_class_pe": [
          "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
        ],
        "pharm_class_moa": [
          "Organic Cation Transporter 2 Inhibitors [MoA]",
          "Dihydrofolate Reductase Inhibitors [MoA]"
        ],
        "unii": [
          "U3H27498KS"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "9c5e0c2a-800e-47e9-a26b-582b98a05957",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20130118",
      "product_id": "49884-604_9c5e0c2a-800e-47e9-a26b-582b98a05957",
      "application_number": "ANDA201791",
      "brand_name_base": "Lamotrigine Extended Release",
      "pharm_class": [
        "Anti-epileptic Agent [EPC]",
        "Decreased Central Nervous System Disorganized Electrical Activity [PE]",
        "Dihydrofolate Reductase Inhibitors [MoA]",
        "Mood Stabilizer [EPC]",
        "Organic Cation Transporter 2 Inhibitors [MoA]"
      ]
    }
  ]
}